Table 3

Treatment and outcomes, overall and by region

 OverallBy regionp Value
Overall (N=455)Australia and NZ (N=312)SE Asia (N=143)
Treatment in EDN, % (95% CI)N, %, (95% CI)N, %, (95% CI)
Oxygen285; 62% (58% to 67%)186; 60% (54% to 65%)99; 69% (61% to 76)0.06
Non-invasive ventilation56; 12% (10% to 16%)49; 16% (12% to 20%)7; 5% (2% to 10%00.002
Mechanical ventilation4; 1% (0.3% to 2%)2; 0.6% (0.1% to 2.3%)2; 1% (0.4% to 5%)0.81
Diuretic
 Any332; 73% (69% to 77%)
Missing data=2
236; 76% (71% to 81%)
Missing data=2
96; 67% (59% to 74%)
Missing data=0
0.06
 IV303; 67% (62% to 71%)
Missing data=2
210; 68% (62% to 73%)
Missing data=2
93; 65% (57% to 72%)
Missing data=0
0.65
 Oral46; 10% (8% to 13%)
Missing data=2
40; 13% (10% to 17%)
Missing data=6
6; 4% (2% to 9%)
Missing data=0
0.007
Nitrate 
 Any115; 25% (22% to 30)
Missing data=2
72; 23% (19% to 28%)
Missing data=2
43; 30% (23% to 38%)
Missing data=0
0.15
 IV bolus1; 0.2% (0.04% to 1%)
Missing data=2
1; 0.3% (0.06% to 2%)
Missing data=2
0; 0% (0% to 3%)
Missing data=0
0.69
 IV infusion31; 7% (5% to 10%)
Missing data=3
16; 5% (3% to 8%)
Missing data=3
15; 10% (6% to 17%)
Missing data=0
0.06
 Sublingual/transdermal/oral89; 20% (16% to 24%)
Missing data=4
58; 19% (15% to 24%)
Missing data=4
31; 22% (16% to 29%)
Missing data=0
0.56
 Inotrope/vasopressor5; 1% (0.5% to 3%)
Missing data=5
4; 1% (0.5% to 3%)
Missing data=5
1; 0.7% (0.1% to 4%)
Missing data=0
0.92
 Morphine16; 4% (2% to 6%)
Missing data=6
14; 5% (3% to 8%)
Missing data=6
2; 1% (0.4% to 5%)
Missing data=0
0.16
 Anticoagulant31; 7% (5% to 10%)
Missing data=5
26; 8% (6% to 12%)
Missing data=5
5; 4% (2% to 8%)
Missing data=0
0.08
 Antiplatelet agent40; 9% (7% to 12%)
Missing data=5
28; 9% (6% to 13%)
Missing data=5
12; 8% (5% to 14%)
Missing data=0
0.92
 Antibiotic71; 16% (13% to 19%)
Missing data=5
59; 19% (15% to 24%)
Missing data=5
12; 8% (5% to 14%)
Missing data=0
0.005
 Systemic corticosteroid26; 6% (4% to 8%)
Missing data=5
25; 8% (6% to 12%)
Missing data=5
1; 0.7% (0.1% to 4%)
Missing data=0
0.003
 Inhaled bronchodilator58; 13% (10% to 16%)
Missing data=5
49; 16% (12% to 20%)
Missing data=5
9; 6% (3% to 11%)
Missing data=0
0.007
Treatment combinationsN, % (95% CI)N, % (95% CI)N, % (95% CI)
Diuretic+nitrate (any route)97; 21% (18% to 25%)
Missing data=2
59; 19% (15% to 24%)
Missing data=2
38; 27% (20% to 34%)
Missing data=0
0.09
Diuretic+inhaled bronchodilator47; 10% (8% to 14%)
Missing data=5
41; 13% (10% to 18%)
Missing data=5
6; 4% (2% to 9%)
Missing data=0
0.005
Diuretic+antibiotic58; 13% (10% to 16%)
Missing data=5
48; 16% (12% to 20%)
Missing data=5
10; 7% (4% to 12%)
Missing data=0
0.02
Diuretic+nitrate (any route)+antibiotic18; 4% (3% to 6%)
Missing data=6
15; 5% (3% to 8%)
Missing data=6
3; 2% (0.7% to 6%)
Missing data=0
0.25
Diuretic+inhaled bronchodilator+systemic corticosteroid13; 3% (2% to 5%)
Missing data=5
13; 4% (2% to 7%)
Missing data=5
0; 0% (0% to 3%)
Missing data=0
0.03
Diuretic+inhaled bronchodilator+systemic corticosteroid+antibiotic8; 2% (1% to 4%)
Missing data=5
8; 3% (1% to 5%)
Missing data=5
0; 0% (0% to 3%)
Missing data=0
0.12
OutcomeN, % (95% CI)N, % (95% CI)N, % (95% CI)
Admission to hospital ward (including ICU and interhospital transfers for admission)392; 86% (83% to 89%)
Missing data=1
265; 85% (81% to 89%)
Missing data=1
127; 89% (83% to 93%)
Missing data=0
0.37
ICU admission19; 4% (3% to 7%)
Missing data=1
13; 4% (3% to 7%)
Missing data=1
6; 4% (2% to 9%)
Missing data=0
0.81
ED short stay unit management (excludes hospital ward admission)10; 2% (1% to 4%)
Missing data=1
6; 2% (1% to 4%)
Missing data=1
4; 3% (1% to 7%)
Missing data=0
0.81
Length of stay for patients admitted to hospital (days, median, IQR)6, 4 to 9
Missing data=22
6, 3 to 9
Missing data=22
6, 3 to 8
Missing data=0
0.44
Died in ED2; 0.5% (0.1% to 2%)
Missing data=1
2; 0.6% (0.2% to 2%)
Missing data=1
0; 0% (0% to 3%)
Missing data=0
0.58
In-hospital mortality for patients admitted to ward including ICU20; 5% (3% to 7%)
Missing data=22
14; 6% (3% to 9%)
Missing data=22
6; 5% (2% to 10%)
Missing data=0
0.92
  • Data adjusted for missing data.

  • Nitrate: some patients had more than one route of administration.

  • ED, emergency department; ICU, intensive care unit; IV, intravenous; NZ, New Zealand; SE Asia, South East Asia, combined data from Malaysia, Hong Kong and Singapore.